ID17647A - Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan - Google Patents
Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatanInfo
- Publication number
- ID17647A ID17647A IDP972308A ID972308A ID17647A ID 17647 A ID17647 A ID 17647A ID P972308 A IDP972308 A ID P972308A ID 972308 A ID972308 A ID 972308A ID 17647 A ID17647 A ID 17647A
- Authority
- ID
- Indonesia
- Prior art keywords
- propilactic
- disorders
- substance
- treatment
- vision function
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17693396 | 1996-07-05 | ||
| JP21394196 | 1996-08-13 | ||
| JP31403396 | 1996-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID17647A true ID17647A (id) | 1998-01-15 |
Family
ID=27324333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP972308A ID17647A (id) | 1996-07-05 | 1997-07-03 | Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5952338A (id) |
| EP (1) | EP0819431A1 (id) |
| KR (1) | KR980008226A (id) |
| CN (1) | CN1172644A (id) |
| AU (1) | AU2843397A (id) |
| BR (1) | BR9703874A (id) |
| CA (1) | CA2209581A1 (id) |
| HU (1) | HUP9701150A2 (id) |
| ID (1) | ID17647A (id) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| AU2002214325A1 (en) * | 2000-11-20 | 2002-05-27 | Sankyo Company Limited | Process for producing carbapenem-type antibacterial |
| WO2002078673A1 (fr) * | 2001-03-29 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Procede de production d'un medicament sous forme de granules fins |
| EP1374855A1 (en) * | 2001-03-30 | 2004-01-02 | Takeda Chemical Industries, Ltd. | Medicinal solutions |
| JP2003010158A (ja) * | 2001-04-26 | 2003-01-14 | Biochemical & Pharmacological Laboratories Inc | 眼精疲労モデル、その作製方法、そのモデルを用いた評価方法およびその評価法を用いて選択された薬剤 |
| FR2863496A1 (fr) * | 2003-12-12 | 2005-06-17 | Anben Pharma | Composition therapeutique destinee au traitement des troubles de l'accomodation de l'oeil humain |
| US9827250B2 (en) | 2012-07-31 | 2017-11-28 | Johnson & Johnson Vision Care, Inc. | Lens incorporating myopia control optics and muscarinic agents |
| US20230277521A1 (en) * | 2022-03-07 | 2023-09-07 | Harrow Ip, Llc | Extended-release pharmaceutical compositions for treating eye conditions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4299963A (en) * | 1977-03-08 | 1981-11-10 | Takeda Chemical Industries, Ltd. | 1-Azaxanthone derivatives |
| US4143042A (en) * | 1977-03-08 | 1979-03-06 | Takeda Chemical Industries, Ltd. | 1-azaxanthone-3-carboxylic acids |
| US4255576A (en) * | 1977-03-08 | 1981-03-10 | Takeda Chemical Industries, Ltd. | 1-Azaxanthone derivatives |
| CA1095519A (en) * | 1977-03-14 | 1981-02-10 | Harold E. Zaugg | Esters of 1,4-ethano-10-hydroxy-5-oxo-5h-[1] benzopyrano [3,4-b] pyridine |
| JPS5825677B2 (ja) * | 1977-09-26 | 1983-05-28 | 武田薬品工業株式会社 | 3−テトラゾ−ル−1−アザキサントン誘導体およびその製造法 |
| JPS6110587A (ja) * | 1985-01-23 | 1986-01-18 | Takeda Chem Ind Ltd | 1−アザキサントン−3−カルボン酸誘導体およびその製造法 |
| JPS6110588A (ja) * | 1985-01-23 | 1986-01-18 | Takeda Chem Ind Ltd | 1−アザキサントン誘導体およびその製造法 |
| US4728509A (en) * | 1985-08-19 | 1988-03-01 | Takeda Chemical Industries, Ltd. | Aqueous liquid preparation |
| US5519030A (en) * | 1993-10-07 | 1996-05-21 | Senju Pharmaceutical Co., Ltd. | Method for prophylaxis and treatment of myopia |
-
1997
- 1997-07-01 US US08/886,270 patent/US5952338A/en not_active Expired - Fee Related
- 1997-07-01 KR KR1019970030523A patent/KR980008226A/ko not_active Withdrawn
- 1997-07-02 EP EP97110899A patent/EP0819431A1/en not_active Withdrawn
- 1997-07-02 AU AU28433/97A patent/AU2843397A/en not_active Withdrawn
- 1997-07-03 ID IDP972308A patent/ID17647A/id unknown
- 1997-07-04 CA CA002209581A patent/CA2209581A1/en not_active Abandoned
- 1997-07-04 HU HU9701150A patent/HUP9701150A2/hu unknown
- 1997-07-05 CN CN97115533A patent/CN1172644A/zh active Pending
- 1997-07-07 BR BR9703874A patent/BR9703874A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2843397A (en) | 1998-01-15 |
| BR9703874A (pt) | 1998-09-01 |
| HUP9701150A2 (hu) | 1999-02-01 |
| KR980008226A (ko) | 1998-04-30 |
| CN1172644A (zh) | 1998-02-11 |
| HU9701150D0 (en) | 1997-09-29 |
| EP0819431A1 (en) | 1998-01-21 |
| CA2209581A1 (en) | 1998-01-05 |
| MX9705077A (es) | 1998-05-31 |
| US5952338A (en) | 1999-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID23600A (id) | Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453) | |
| NO976063D0 (no) | Fremgangsmåte for behandling av diabetes | |
| DE69823459D1 (de) | Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen | |
| DE69833948D1 (de) | Aktives system zur frühen zerstörung von schleppwirbeln | |
| DE69838386D1 (de) | Beleuchtungssystem und dessen anwendung | |
| DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
| ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
| EE9900607A (et) | Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks | |
| NO306977B1 (no) | Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen | |
| DE69841076D1 (de) | System implantierbarer geräte zur beobachtung und beeinflussung von körperparametern | |
| ID19385A (id) | Adesif termosetting dan metoda pembuatannya | |
| ID22807A (id) | Hasil derifat 1-aril dan piridilpirazol untuk pestisida | |
| ID17116A (id) | Komposisi senyawa turunan 6-fenilpiridil-2-amina dan penggunaannya dalam pengobatan dan gangguan sistem syaraf pusat | |
| PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
| NO963049L (no) | Modulatorer av forankrende proteinfunksjon | |
| DE69731341D1 (de) | Optisches Bauelement und optisches System mit diesem | |
| BR9707922A (pt) | Cafeína e clemastina para tratamento de distúrbios respiratórios | |
| ID22283A (id) | Kombinasi terapi baru dari zat-zat mirtazapin dan antipsikotik untuk perawatan atau propilaksis gangguan psikotik | |
| NO991459D0 (no) | Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner | |
| DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
| ID17647A (id) | Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan | |
| NO984432L (no) | FremgangsmÕte for behandling av migrenesmerte | |
| DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
| DE69739190D1 (de) | Arzneimittel zur behandlung von oculären kreislauferkrankungen | |
| ATE346840T1 (de) | Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung |